Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse

[1]  J. Meinzen-Derr,et al.  Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome. , 2015, The Journal of pediatrics.

[2]  M. Kogevinas,et al.  Prenatal Second-Hand Smoke Exposure Measured with Urine Cotinine May Reduce Gross Motor Development at 18 Months of Age. , 2015, The Journal of pediatrics.

[3]  Shoo K. Lee,et al.  Adverse Impact of Maternal Cigarette Smoking on Preterm Infants: A Population-Based Cohort Study , 2015, American Journal of Perinatology.

[4]  J. Meinzen-Derr,et al.  Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. , 2015, The Journal of pediatrics.

[5]  V. Phupong,et al.  Evaluation of the performance of the insulin-like growth factor-binding protein-1/alpha-fetoprotein test in diagnosing ruptured fetal membranes in pregnant women , 2015, Journal of Perinatology.

[6]  J. Sackoff,et al.  Reliability of Reported Maternal Smoking: Comparing the Birth Certificate to Maternal Worksheets and Prenatal and Hospital Medical Records, New York City and Vermont, 2009 , 2015, Maternal and Child Health Journal.

[7]  Carolyn C Johnson,et al.  Accuracy of self‐reported smoking cessation during pregnancy , 2015, Acta obstetricia et gynecologica Scandinavica.

[8]  Riccardo Polosa,et al.  Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review , 2014, Therapeutic advances in drug safety.

[9]  P. Tsao,et al.  Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. , 2014, Pediatrics and neonatology.

[10]  A. Dotta,et al.  Neonatal abstinence syndrome , 2013 .

[11]  Denise V. D’Angelo,et al.  Trends in smoking before, during, and after pregnancy--Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010. , 2009, Morbidity and mortality weekly report. Surveillance summaries.

[12]  Y. Balhara,et al.  A receiver operated curve-based evaluation of change in sensitivity and specificity of cotinine urinalysis for detecting active tobacco use. , 2013, Journal of cancer research and therapeutics.

[13]  S. Dube,et al.  Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. , 2011, American journal of epidemiology.

[14]  M. Noland,et al.  The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes. , 2010, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[15]  M. Aliyu,et al.  Intrauterine exposure to tobacco and risk of medically indicated and spontaneous preterm birth. , 2010, American journal of perinatology.

[16]  Committee opinion no. 471: Smoking cessation during pregnancy. , 2010, Obstetrics and gynecology.

[17]  V. Dukic,et al.  Calibrating Self-Reported Measures of Maternal Smoking in Pregnancy via Bioassays Using a Monte Carlo Approach , 2009, International journal of environmental research and public health.

[18]  N. Benowitz,et al.  Nicotine chemistry, metabolism, kinetics and biomarkers. , 2009, Handbook of experimental pharmacology.

[19]  Yun-Mi Song,et al.  Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. Jalaludin,et al.  Influence of previous pregnancy outcomes and continued smoking on subsequent pregnancy outcomes: an exploratory study in Australia , 2008, BJOG : an international journal of obstetrics and gynaecology.

[21]  S. Markowitz.  The Effectiveness of Cigarette Regulations in Reducing Cases of Sudden Infant Death Syndrome , 2006, Journal of health economics.

[22]  R. Wickström.  Effects of Nicotine During Pregnancy: Human and Experimental Evidence , 2007, Current neuropharmacology.

[23]  Rosalind J Wright,et al.  Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. , 2005, Paediatric and perinatal epidemiology.

[24]  G. Alexander,et al.  Levels of Excess Infant Deaths Attributable to Maternal Smoking During Pregnancy in the United States , 2003, Maternal and Child Health Journal.

[25]  N. Benowitz,et al.  Accelerated metabolism of nicotine and cotinine in pregnant smokers. , 2002, The Journal of pharmacology and experimental therapeutics.

[26]  S. Jee,et al.  Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  J. Pirkle,et al.  Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. , 2000, Journal of analytical toxicology.

[28]  K. Reijula,et al.  Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry. , 1999, Clinical chemistry.

[29]  V. Haufroid,et al.  Urinary cotinine as a tobacco-smoke exposure index: a minireview , 1998, International archives of occupational and environmental health.

[30]  J. Mcfarlane,et al.  Physical abuse, smoking, and substance use during pregnancy: prevalence, interrelationships, and effects on birth weight. , 1996, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[31]  N. Benowitz,et al.  Cotinine as a biomarker of environmental tobacco smoke exposure. , 1996, Epidemiologic reviews.

[32]  C. Hobel,et al.  Maternal Tobacco Use and Substance Abuse: Reported Prevalence Rates and Associations With the Delivery of Small for Gestational Age Neonates , 1993, Obstetrics and gynecology.

[33]  R. Etzel.  A review of the use of saliva cotinine as a marker of tobacco smoke exposure. , 1990, Preventive medicine.